Executive SummaryIndia's IPO process involves a structured 9–12 month timeline governed by SEBI regulations, requiring companies to navigate multiple stages including DRHP filing, merchant banker engagement, regulatory approvals, and stock exchange listing. Understanding this timeline is critical for CFOs, audit teams, and compliance professionals managing capital market transactions.
What Happened
The Securities and Exchange Board of India (SEBI) has established a defined IPO process with clear month-by-month milestones that guide companies from initial preparation through final listing on stock exchanges. This structured approach, detailed in SEBI's ICDR (Issue of Capital and Disclosure Requirements) Regulations, 2018, and subsequent amendments, provides a transparent roadmap for listed and unlisted companies seeking to raise capital through public offerings.
The timeline typically spans 9–12 months, beginning with pre-IPO preparation and concluding with listing and commencement of trading. Key regulatory touchpoints include engagement of merchant bankers and other intermediaries (Month 1–2), preparation and filing of the Draft Red Herring Prospectus (DRHP) with SEBI (Month 2–3), SEBI review and comments (Month 4–5), filing of the Red Herring Prospectus (RHP) post-approval (Month 6), public subscription period (Month 7), share allotment and listing approval (Month 8), and final listing and commencement of trading (Month 9). Variations occur based on the scale of the offering, regulatory feedback, and market conditions.
Why It Matters
For finance professionals and compliance teams, understanding this timeline is essential for several reasons. First, it facilitates accurate financial reporting and disclosure. Companies must prepare audited financial statements for the preceding 2–3 financial years, often requiring restatement under Ind AS (Indian Accounting Standards) if the company was previously operating under IGAAP. SEBI mandates that financials included in prospectuses reflect true and fair view principles aligned with ICAI guidance notes.
Second, the IPO process triggers heightened governance and audit requirements. Independent auditors must provide comfort on the accuracy of historical financials, the reasonableness of revenue recognition policies, and compliance with section 143(12) of the Companies Act, 2013, which requires auditors to report specific matters to the board's audit committee. Internal audit frameworks must be strengthened and documented.
Third, delayed regulatory approvals or comments can extend the timeline significantly, impacting working capital planning, investor communications, and market timing. Companies must budget for professional fees (merchant bankers, auditors, legal counsel, valuers) across a longer timeframe than anticipated. Additionally, any material adverse change disclosed during the process can trigger fresh SEBI review and potential repricing of the offering.
Finally, the timeline intersects with tax compliance. Companies must ensure GST compliance on advisory fees, satisfy Direct Tax withholding obligations under the Income Tax Act, 1961, and disclose all contingent liabilities and pending litigation in the prospectus, as required by Schedule VI of the Companies Act, 2013.
Practical Impact
For CFOs and finance teams, the month-by-month timeline demands parallel execution of multiple workstreams. During Months 1–3, the company must appoint a merchant banker (typically a consortium of 2–3 lead managers), finalize draft financials with auditors, and prepare the DRHP disclosure, which includes a detailed 'Risk Factors' section, 'Business Description,' 'Financial Information,' and 'Use of Proceeds.' SEBI's review cycle (Months 4–5) often generates 2–3 rounds of comments requiring responses, revisions to prospectus language, and restatement of data—each requiring coordination between auditors, legal advisors, and company management.
Audit teams should expect intensified fieldwork during this period. Statutory auditors will perform substantive testing on revenue, receivables, and inventory to provide comfort on historical financial statements. Auditors also validate the 'Management Discussion & Analysis' (MD&A) section against regulatory templates and benchmark industry metrics. Post-approval (Months 6–8), during the subscription and allotment phase, auditors may be required to provide comfort letters on the financial statements as of a specified date immediately preceding listing.
Compliance professionals must ensure all statutory filings under MCA regulations are current, all pending litigation is disclosed, and all regulatory approvals (from sector-specific regulators, if applicable) are obtained. For instance, telecom or insurance companies face additional sector regulator approvals, extending the timeline.
Post-listing (Month 9 onwards), the company enters a new compliance regime: continuous disclosure obligations under SEBI's Listing Regulations, 2015, quarterly and annual financial reporting requirements under Schedule III, and expanded governance obligations including independent director nominations and audit committee composition. Finance teams must budget for increased professional compliance costs and audit fees in the first post-listing year.
Key Takeaways
- →IPO timeline spans 9–12 months with defined SEBI milestones; finance teams must align audit cycles and financial reporting calendars accordingly to meet DRHP filing deadlines.
- →Auditors must provide comfort on historical financial statements under Ind AS; companies transitioning from IGAAP should begin restatement workstreams early to avoid delays in Months 2–3.
- →Prospectus preparation requires detailed disclosure of contingent liabilities, pending litigation, and tax risks; audit teams should coordinate with legal counsel to ensure completeness and compliance with Schedule VI requirements.
- →Post-listing compliance burden increases significantly, including continuous disclosure obligations, quarterly MD&A filings, and expanded audit committee oversight—budget for additional professional advisory costs.
- →Any material adverse change, regulatory comment, or market condition during Months 4–8 can extend timelines and trigger repricing; maintain contingency timelines and scenario planning in IPO project governance.
Disclaimer: This update is for general information only and does not constitute legal, tax or professional advice. Regulatory positions may change. Please consult APRA & Associates LLP for advice specific to your business. Contact us.